Cutanea Life Sciences

Wayne, United States Founded: 2005 • Age: 21 yrs Acquired By Biofrontera
Therapeutics for skin disorders like acne and psoriasis are developed.
Request Access

About Cutanea Life Sciences

Cutanea Life Sciences is a company based in Wayne (United States) founded in 2005 was acquired by Biofrontera in March 2019.. Cutanea Life Sciences has raised $900 thousand across 3 funding rounds from investors including Biofrontera. Cutanea Life Sciences operates in a competitive market with competitors including Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others.

  • Headquarter Wayne, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $900 K (USD)

    in 3 rounds

  • Latest Funding Round
    $450 K (USD), Seed

    Sep 01, 2011

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Biofrontera

    (Mar 25, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Cutanea Life Sciences

Cutanea Life Sciences has successfully raised a total of $900K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $450 thousand completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Seed — $450,000
  • First Round
  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2011 Amount Seed - Cutanea Life Sciences Valuation

investors

Jul, 2011 Amount Debt – Conventional - Cutanea Life Sciences Valuation

investors

Jul, 2011 Amount Seed - Cutanea Life Sciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cutanea Life Sciences

Cutanea Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Biofrontera. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Solutions for dermatological therapeutics and consumer products are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cutanea Life Sciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cutanea Life Sciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cutanea Life Sciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cutanea Life Sciences

Cutanea Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Developer of drugs for treating dermatology diseases
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
Immunotherapeutic solutions for dermatological conditions are developed.
domain founded_year HQ Location
Microbial therapeutics for skin diseases are developed.
domain founded_year HQ Location
Nitric oxide-based therapeutics for dermatology disorders are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cutanea Life Sciences

Frequently Asked Questions about Cutanea Life Sciences

When was Cutanea Life Sciences founded?

Cutanea Life Sciences was founded in 2005 and raised its 1st funding round 6 years after it was founded.

Where is Cutanea Life Sciences located?

Cutanea Life Sciences is headquartered in Wayne, United States.

Who is the current CEO of Cutanea Life Sciences?

Robert Bitterman is the current CEO of Cutanea Life Sciences.

Is Cutanea Life Sciences a funded company?

Cutanea Life Sciences is a funded company, having raised a total of $900K across 3 funding rounds to date.

What does Cutanea Life Sciences do?

Cutanea Life Sciences was established in 2005 in Wayne, United States, within the biotechnology sector focused on dermatology. Therapeutics targeting skin conditions such as acne, psoriasis, rosacea, atopic dermatitis, and HPV-induced warts are developed. A soft tissue implant remains in preclinical stages. Aktipak, combining erythromycin and benzoyl peroxide in gel form, is prescribed for acne vulgaris treatment.

Who are the top competitors of Cutanea Life Sciences?

Cutanea Life Sciences's top competitors include LEO Pharma, Formation Bio and Arcutis.

Who are Cutanea Life Sciences's investors?

Cutanea Life Sciences has 1 investor. Key investors include Biofrontera.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available